Announcements Trials
Browse Landscape

Phase

Phase 1 19Phase 2 12Phase 1/2 9Phase EARLY_PHASE1 4Phase 3 4Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 168Neoplasms 132Prostatic Neoplasms 71Lung Neoplasms 67Colorectal Neoplasms 65Motor Activity 39Uterine Cervical Neoplasms 36Pancreatic Neoplasms 30Ovarian Neoplasms 27Head and Neck Neoplasms 27Brain Neoplasms 25Carcinoma, Non-Small-Cell Lung 23Rectal Neoplasms 21Glioblastoma 20Colonic Neoplasms 20Carcinoma, Hepatocellular 20Stomach Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Disease 16Depression 16Anxiety Disorders 16Hematologic Neoplasms 15Melanoma 14Leukemia 14Papillomavirus Infections 13Squamous Cell Carcinoma of Head and Neck 12Multiple Myeloma 12Glioma 12Carcinoma, Renal Cell 12Urinary Bladder Neoplasms 11

Interventions

Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, B-Cell × 30 days × Clear all
NCT07609030 2026-05-27

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
90 enrolled
LymphoidPlasma cell

Multiple Myeloma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡